Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

Nature Reviews Neuroscience

Volumn 3, Issue 11, 2002, Pages 862-872

  LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALCIUM; MEMBRANE PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL; BRAIN; CALCIUM SIGNALING; CELL MEMBRANE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; ROUGH ENDOPLASMIC RETICULUM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CALCIUM; CALCIUM SIGNALING; CELL MEMBRANE; ENDOPLASMIC RETICULUM, ROUGH; HUMANS; MEMBRANE PROTEINS; PRESENILIN-1;

EID: 0036830947     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn960     Document Type: Article

References (145)

1. Sisodia, S. S. & St George-Hyslop, P H. γ-Secretase, Notch, Aβ and Alzheimer's disease: where do the presenilins fit in? Nature Rev. Neurosci. 3, 281-290 (2002).
2. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
3. Khachaturian, Z. S. Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview. Ann. NY Acad. Sci. 568, 1-4 (1989).
4. Mattson, M. P et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222-229 (2000).
5. Etcheberrigaray, R. et al. Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol. Dis. 5, 37-45 (1998).
6. Larson, J., Lynch, G., Games, D. & Seubert, P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23-35 (1999).
7. Guo, Q. et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med. 5, 101-106 (1999).
8. Leissring, M. A. et al. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793-798 (2000).
9. Mattson, M. P. et al. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389 (1992).
10. Mattson, M. P, Tomaselli, K. J. & Rydel, R. E. Calcium- destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49 (1993).
11. Yoo, A. S. et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27, 561-572 (2000).
12. Chui, D. H. et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5, 560-564 (1999).
13. Leissring, M. A. et al. A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP Proc. Natl Acad. Sci. USA 99, 4697-4702 (2002).
14. Mattson, M. P, Lovell, M. A., Ehmann, W. D. & Markesbery, W. R. Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity. Brain Res. 602, 21-31 (1993).
15. 2+influx in cultured hippocampal neurons. Neuron 4, 105-117 (1990).
16. Zheng, H. et al. Mice deficient for the amyloid precursor protein gene. Ann. NY Acad. Sci. 777, 421-426 (1996).
17. Heber, S. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963 (2000).
18. von Koch, C. S. et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669 (1997).
19. Kamal, A., Stokin, G. B., Yang, Z., Xia, C. H. & Goldstein, L. S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449-459 (2000).
20. Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A. & Goldstein, L. S. Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP. Nature 414, 643-648 (2001).
21. o. Nature 362, 75-79 (1993).
22. Okamoto, T. et al. Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. EMBO J. 15, 3769-3777 (1996).
23. Mbebi, C. et al. Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J. Biol. Chem. 277, 20979-20990 (2002).
24. Le, Y. et al. Amyloid β42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123 (2001).
25. Cao, X. & Sudhof, T. C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120 (2001).
26. Goodman, Y. & Mattson, M. P Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid p-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12 (1994).
27. Mattson, M. P. et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243-254 (1993).
28. Mattson, M. P. Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25, 439-450 (1994).
29. 2+ increase in rat cultured hippocampal neurones. Br. J. Pharmacol. 123, 1483-1489 (1998).
30. Barger, S. W., Fiscus, R. R., Ruth, P., Hofmann, F. & Mattson, M. P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096 (1995).
31. Li, W. Y. et al. Suppression of an amyloid β peptide- mediated calcium channel response by a secreted β-amyloid precursor protein. Neuroscience 95, 1-4 (2000).
32. Guo, Q., Robinson, N. & Mattson, M. P. Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF- κB and stabilization of calcium homeostasis. J. Biol. Chem. 273, 12341-12351 (1998).
33. Meziane, H. et al. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc. Natl Acad. Sci. USA 95, 12683-12688 (1998).
34. Mattson, M. P. Calcium and neuronal injury in Alzheimer's disease. Contributions of β-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. NY Acad. Sci. 747, 50-76 (1994).
35. Nixon, R. A. et al. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747, 77-91 (1994).
36. Mattson, M. P., Engle, M. G. & Rychlik, B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol. Chem. Neuropathol. 15, 117-142 (1991).
37. Mattson, M. P., Barger, S. W., Begley, J. G. & Mark, R. J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216 (1995).
38. Mattson, M. P. Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid β-peptide? Neurobiol. Aging 16, 679-682 (1995).
39. Gibson, G. E. et al. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol. Aging 18, 573-580 (1997).
40. Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R. & Lin, M. C. The channel hypothesis of Alzheimer's disease: current status. Peptides 23, 1311-1315 (2002).
41. Arispe, N., Rojas, E. & Pollard, H. B. Alzheimer disease amyloid p protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl Acad. Sci. USA 90, 567-571 (1993).
42. Arispe, N., Pollard, H. B. & Rojas, E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl Acad. Sci. USA 90, 10573-10577 (1993).
43. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease. Ann. NY Acad. Sci. 747, 256-266 (1994).
44. 2+- channel hypothesis for neuronal death in Alzheimer disease. Mol. Cell. Biochem. 140, 119-125 (1994).
45. Bhatia, R., Lin, H. & Lal, R. Fresh and globular amyloid β protein (1 -42) induces rapid cellular degeneration: evidence for AβP channel-mediated cellular toxicity. FASEB J. 14, 1233-1243 (2000).
46. Kawahara, M. & Kuroda, Y. Molecular mechanism of neurodegeneration induced by Alzheimer's β-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53, 389-397 (2000).
47. Lin, M. C., Mirzabekov, T. & Kagan, B. L. Channel formation by a neurotoxic prion protein fragment. J. Biol. Chem. 272, 44-47 (1997).
48. Mirzabekov, T. A., Lin, M. C. & Kagan, B. L. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988-1992 (1996).
49. Kawahara, M., Kuroda, Y., Arispe, N. & Rojas, E. Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083 (2000).
50. Hensley, K. et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 3270-3274 (1994).
51. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249 (1995).
52. Goodman, Y., Bruce, A. J., Cheng, B. & Mattson, M. P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844 (1996).
53. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid p-peptide and iron. J. Neurosci. Res. 50, 522-530 (1997).
54. Querfurth, H. W. & Selkoe, D. J. Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33, 4550-4561 (1994).
55. Querfurth, H. W., Jiang, J., Geiger, J. D. & Selkoe, D. J. Caffeine stimulates amyloid β-peptide release from p-amyloid precursor protein-transfected HEK293 cells. J. Neurochem. 69, 1580-1591 (1997).
56. Buxbaum, J. D., Ruefli, A. A., Parker, C. A., Cypess, A. M. & Greengard, P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl Acad. Sci. USA 91, 4489-4493 (1994).
57. Akbari, Y. et al. Modulation of β-amyloid production through calcium signaling pathways. Soc. Neurosci. Abstr. 28 (in the press).
58. V42 is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. 3, 1021-1023 (1997).
59. Selkoe, D. J. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc. Natl Acad. Sci. USA 98, 11039-11041 (2001).
60. De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390 (1998).
61. De Strooper, B. et al. A presenilin-1-dependent y-secretase- like protease mediates release of Notch intracellular domain. Nature 398, 518-522 (1999).
62. Ni, C. Y., Murphy, M. P., Golde, T. E. & Carpenter, G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
63. Lee, H. J. et al. Presenilin-dependent γ-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277, 6318-6323 (2002).
64. Marambaud, P et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21, 1948-1956 (2002).
65. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased In vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
66. Li, Y. M. et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689-694 (2000).
67. Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517 (1999).
68. Wolfe, M. S. & Selkoe, D. J. Intramembrane proteases — mixing oil and water. Science 296, 2156-2157 (2002).
69. Wolfe, M. S. Presenilin and γ-secretase: structure meets function. J. Neurochem. 76, 1615-1620 (2001).
70. Weihofen, A., Binns, K., Lemberg, M. K., Ashman, K. & Martoglio, B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296, 2215-22218 (2002).
71. Wahrle, S. et al. Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9, 11-23 (2002).
72. Yu, G. et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and PAPP processing. Nature 407, 48-54 (2000).
73. Francis, R. et al. aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev. Cell 3, 85-97 (2002).
74. Kopan, R. & Goate, A. Aph-2/Nicastrin: an essential component of γ-secretase and regulator of Notch signaling and Presenilin localization. Neuron 33, 321-324 (2002).
75. Wilson, C. A., Doms, R. W., Zheng, H. & Lee, V M. Presenilins are not required for AP42 production in the early secretory pathway. Nature Neurosci. 5, 849-855 (2002).
76. Nakajima, M., Miura, M., Aosaki, T. & Shirasawa, T. Deficiency of presenilin-1 increases calcium-dependent vulnerability of neurons to oxidative stress in vitro. J. Neurochem. 78, 807-814 (2001).
77. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 534-538 (1994).
78. Leissring, M. A., Paul, B. A., Parker, I., Cotman, C. W. & LaFerla, F. M. Alzheimer's presenilin-1 mutation potentiates inositol 1, 4, 5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J. Neurochem. 72, 1061-1068 (1999).
79. 2+entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation. Brain Res. (in the press).
80. Raymond, C. R. & Redman, S. J. Different calcium sources are narrowly tuned to the induction of different forms of LTP J. Neurophysiol. 88, 249-255 (2002).
81. Parent, A., Linden, D. J., Sisodia, S. S. & Borchelt, D. R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6, 56-62 (1999).
82. Zaman, S. H. et al. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine. Neurobiol. Dis. 7, 54-63 (2000).
83. Barrow, P. A. et al. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 7, 119-126 (2000).
84. Chan, S. L., Mayne, M., Holden, C. P., Geiger, J. D. & Mattson, M. P Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275, 18195-18200 (2000).
85. Cedazo-Minguez, A., Popescu, B. O., Ankarcrona, M., Nishimura, T. & Cowburn, R. F. The presenilin 1 AE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J. Biol. Chem. 277, 36646-36655 (2002).
86. Guo, Q., Christakos, S., Robinson, N. & Mattson, M. P Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl Acad. Sci. USA 95, 3227-3232 (1998).
87. Buxbaum, J. D. et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nature Med. 4, 1177-1181 (1998).
88. Leissring, M. A. et al. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl Acad. Sci. USA 97, 8590-8593 (2000).
89. Putney, J. W. Jr, Broad, L. M., Braun, F. J., Lievremont, J. P. & Bird, G. S. Mechanisms of capacitative calcium entry. J. Cell Sci. 114, 2223-2229 (2001).
90. Van Leuven, F., Dewachter, I., Herms, J. & Godaux, E. APP and PS1 overexpressing and deficient mice: is calcium homeostasis the crux in Alzheimer's disease? Proc. Int. Conf. Alzheimers Dis. Relat. Disord. 8, 911 (2002).
91. Van Gassen, G., Annaert, W. & Van Broeckhoven, C. Binding partners of Alzheimer's disease proteins: are they physiologically relevant? Neurobiol. Dis. 7, 135-151 (2000).
92. Stabler, S. M., Ostrowski, L. L., Janicki, S. M. & Monteiro, M. J. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J. Cell Biol. 145, 1277-1292 (1999).
93. Shinozaki, K. et al. The presenilin 2 loop domain interacts with the µ-calpain C-terminal region. Int. J. Mol. Med. 1, 797-799 (1998).
94. Pack-Chung, E. et al. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J. Biol. Chem. 275, 14440-14445 (2000).
95. Leissring, M. A., Parker, I. & LaFerla, F. M. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4, 5- trisphosphate-mediated calcium signals. J. Biol. Chem. 274, 32535-32538 (1999).
96. Passer, B. et al. Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer's amyloid-β protein precursor. J. Alzheimers Dis. 2, 289-301 (2000).
97. Yu, C. et al. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment y. Evidence for distinct mechanisms involved in y-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 43756-43760 (2001).
98. Moehlmann, T. et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production. Proc. Natl Acad. Sci. USA 99, 8025-8030 (2002).
99. Weidemann, A. et al. A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 2825-2835 (2002).
100. Gu, Y. et al. Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase- like cleavage of Notch. J. Biol. Chem. 276, 35235-35238 (2001).
101. Edbauer, D., Willem, M., Lammich, S., Steiner, H. & Haass, C. Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 13389-13393 (2002).
102. Kimberly, W. T, Zheng, J. B., Guenette, S. Y. & Selkoe, D. J. The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276, 40288-40292 (2001).
103. Fiore, F. et al. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270, 30853-30856 (1995).
104. Minopoli, G. et al. The β-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J. Biol. Chem. 276, 6545-6550 (2001).
105. Chow, N., Korenberg, J. R., Chen, X. N. & Neve, R. L. APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J. Biol. Chem. 271, 11339-11346 (1996).
106. Borg, J. P., Ooi, J., Levy, E. & Margolis, B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229-6241 (1996).
107. Tanahashi, H. & Tabira, T. X11L2, a new member of the X11 protein family, interacts with Alzheimer's β-amyloid precursor protein. Biochem. Biophys. Res. Commun. 255, 663-667 (1999).
108. Homayouni, R., Rice, D. S., Sheldon, M. & Curran, T. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J. Neurosci. 19, 7507-7515 (1999).
109. Tomita, S. et al. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem. 274, 2243-2254 (1999).
110. Matsuda, S. et al. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J. Neurosci. 21, 6597-6607 (2001).
111. Tarr, P. E., Roncarati, R., Pelicci, G., Pelicci, P. G. & D'Adamio, L. Tyrosine phosphorylation of the β-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J. Biol. Chem. 277, 16798-16804 (2002).
112. Russo, C. et al. Signal transduction through tyrosine- phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J. Biol. Chem. 277, 35282-35288 (2002).
113. Gao, Y. & Pimplikar, S. W. The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl Acad. Sci. USA 98, 14979-14984 (2001).
114. Zheng, P., Eastman, J., Vande Pol, S. & Pimplikar, S. W. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. Proc. Natl Acad. Sci. USA 95, 14745-14750 (1998).
115. Scheinfeld, M. H., Ghersi, E., Laky, K., Fowlkes, B. J. & D'Adamio, L. Processing of β-amyloid precursor like protein-1 and -2 by γ-secretase regulates transcription. J. Biol. Chem. 12 September 2002 (doi:10.1074/jbc.M208110200).
116. Roncarati, R. et al. The y-secretase-generated intracellular domain of β-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc. Natl Acad. Sci. USA 99, 7102-7107 (2002).
117. Kinoshita, A., Whelan, C. M., Berezovska, O. & Hyman, B. T. The γ secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277, 28530-28536 (2002).
118. Veinbergs, I., Mallory, M., Sagara, Y. & Masliah, E. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur. J. Neurosci. 12, 4541-4546 (2000).
119. Ohm, T. G. et al. Apolipoprotein E and βA4-amyloid: signals and effects. Biochem. Soc. Symp. 67, 121-129 (2001).
120. Lalowski, M. et al. The 'nonamyloidogenic' p3 fragment (amyloid β17-42) is a major constituent of Down's syndrome cerebellar preamyloid. J. Biol. Chem. 271, 33623-33631 (1996).
121. Tekirian, T. L. et al. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J. Neuropathol. Exp. Neurol. 57, 76-94 (1998).
122. Vassar, R. et al. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
123. 2+ release channels. Proc. Natl Acad. Sci. USA 99, 7711-7716 (2002).
124. Berridge, M. J., Lipp, P. & Bootman, M. D. The versatility and universality of calcium signalling. Nature Rev. Mol. Cell Biol. 1, 11-21 (2000).
125. 2+ liberation in Xenopus oocytes: hot spots, puffs and blips. Cell Calcium 20, 105-121 (1996).
126. 2+ evoked by inositol trisphosphate in Xenopus oocytes. J. Physiol. (Lond.) 482, 533-553 (1995).
127. 2+ signalling events in Xenopus oocytes. J. Physiol. (Lond.) 509, 67-80 (1998)
128. Leissring, M. A., LaFerla, F. M., Callamaras, N. & Parker, I. Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling. Neurobiol. Dis. 8, 469-478 (2001).
129. Guo, Q. et al. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport 8, 379-383 (1996).
130. Begley, J. G., Duan, W., Chan, S., Duff, K. & Mattson, M. P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72, 1030-1039 (1999).
131. Guo, Q. et al. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72, 1019-1029 (1999).
132. Gibson, G. E., Zhang, H., Toral-Barza, L., Szolosi, S. & Tofel- Grehl, B. Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. Biochim. Biophys. Acta 1316, 71-77 (1996).
133. Gibson, G. E., Nielsen, P., Sherman, K. A. & Blass, J. P. Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol. Psychiatry 22, 1079-1086 (1987).
134. Hirashima, N. et al. Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol. Aging 17, 549-555 (1996).
135. Peterson, C., Ratan, R. R., Shelanski, M. L. & Goldman, J. E. Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. Proc. Natl Acad. Sci. USA 83, 7999-8001 (1986).
136. Peterson, C., Gibson, G. E. & Blass, J. P. Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N. Engl. J. Med. 312, 1063-1065 (1985).
137. Peterson, C. & Goldman, J. E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl Acad. Sci. USA 83, 2758-2762 (1986).
138. Peterson, C., Ratan, R. R., Shelanski, M. L. & Goldman, J. E. Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium. Neurobiol. Aging 9, 261-266 (1988).
139. Peterson, C., Ratan, R., Shelanski, M. & Goldman, J. Changes in calcium homeostasis during aging and Alzheimer's disease. Ann. NY Acad. Sci. 568, 262-270 (1989).
140. Tatebayashi, Y. et al. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia 6, 9-16 (1995).
141. Guo, Q. et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222 (1997).
142. Keller, J. N., Guo, Q., Holtsberg, F. W., Bruce-Keller, A. J. & Mattson, M. P. Increased sensitivity to mitochondrial toxin- induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18, 4439-4450 (1998).
143. Furukawa, K., Guo, Q., Schellenberg, G. D. & Mattson, M. P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52, 618-624 (1998).
144. Popescu, B. O. et al. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 66, 122-134 (2001).
145. Schneider, I. et al. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276, 11539-11544 (2001).